International Patent: INHIBITOR OF THE HETEROCHROMATIN PROTEIN 1 (HP1) FOR MODULATING TH CELLS

GENEVA, July 1 -- INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE filed a patent application (EP2025/085901) for “INHIBITOR OF THE HETEROCHROMATIN PROTEIN 1 (HP1) FOR MODULATING TH CELLS”. With publication no. WO/2026/125263, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/546

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....